149 related articles for article (PubMed ID: 35661836)
1. C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Elhadad S; Chadburn A; Magro C; Van Besien K; Roberson EDO; Atkinson JP; Terry H; Greenberg J; Reid W; Chapin J; Copertino D; Geramfard S; Rodriguez LB; Orfali N; Gerghis U; Shore T; Mayer S; Ahamed J; Laurence J
Bone Marrow Transplant; 2022 Sep; 57(9):1445-1447. PubMed ID: 35661836
[No Abstract] [Full Text] [Related]
2. Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation.
Alhomoud M; Magro C; Seshan S; Zhang T; Gomez-Arteaga A; Chokr N; Yamshon S; Phillips A; Mayer S; Shore T; Laurence J
Bone Marrow Transplant; 2023 Nov; 58(11):1270-1274. PubMed ID: 37604872
[No Abstract] [Full Text] [Related]
3. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
Elhadad S; Chapin J; Copertino D; Van Besien K; Ahamed J; Laurence J
Clin Exp Immunol; 2021 Jan; 203(1):96-104. PubMed ID: 32681658
[TBL] [Abstract][Full Text] [Related]
4. MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence.
Elhadad S; Redmond D; Huang J; Tan A; Laurence J
Clin Exp Immunol; 2023 Jul; 213(2):252-264. PubMed ID: 37191586
[TBL] [Abstract][Full Text] [Related]
5. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Jodele S; Fukuda T; Vinks A; Mizuno K; Laskin BL; Goebel J; Dixon BP; Teusink A; Pluthero FG; Lu L; Licht C; Davies SM
Biol Blood Marrow Transplant; 2014 Apr; 20(4):518-25. PubMed ID: 24370861
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy following haematopoietic stem cell transplant.
Seaby EG; Gilbert RD
Pediatr Nephrol; 2018 Sep; 33(9):1489-1500. PubMed ID: 28993886
[TBL] [Abstract][Full Text] [Related]
7. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
8. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
9. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.
Vasu S; Wu H; Satoskar A; Puto M; Roddy J; Blum W; Klisovic R; Andritsos L; Hofmeister C; Benson DM; Efebera Y; Jaglowski S; Penza S; Cohen D; Devine S; Cataland S
Bone Marrow Transplant; 2016 Sep; 51(9):1241-4. PubMed ID: 27064689
[No Abstract] [Full Text] [Related]
10. [Changes in diagnostic criteria of thrombotic microangiopathy after stem cell transplantation].
Horváth O; Prohászka Z; Kállay K; Kassa C; Stréhn A; Csordás K; Sinkó J; Kriván G
Orv Hetil; 2017 Jul; 158(27):1043-1050. PubMed ID: 28670985
[TBL] [Abstract][Full Text] [Related]
11. Transplant-associated thrombotic microangiopathy.
Renaudon-Smith E; De La Fuente J; Bain BJ
Am J Hematol; 2016 Nov; 91(11):1160. PubMed ID: 27348509
[No Abstract] [Full Text] [Related]
12. Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?
Vaughn JL; Zhao Q; Epperla N; Puto M; Roddy J; Elder P; Blum W; Klisovic R; Jaglowski S; Penza S; William B; Andritsos L; Brammer JE; Hofmeister C; Efebera Y; Benson D; Devine S; Cataland S; Vasu S
Bone Marrow Transplant; 2019 Jun; 54(6):913-916. PubMed ID: 30413812
[No Abstract] [Full Text] [Related]
13. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Jodele S; Licht C; Goebel J; Dixon BP; Zhang K; Sivakumaran TA; Davies SM; Pluthero FG; Lu L; Laskin BL
Blood; 2013 Sep; 122(12):2003-7. PubMed ID: 23814021
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma.
Sabulski A; Abdullah S; Luebbering N; Aunins B; Castillo C; Lake K; Duell A; Strecker L; Langenberg L; Broomhead W; DiMeo S; Odegard EA; Blackard JT; Ziady AG; Seif AE; Dandoy CE; Laskin BL; Jodele S; Davies SM
Haematologica; 2023 Dec; 108(12):3449-3453. PubMed ID: 37317894
[No Abstract] [Full Text] [Related]
15. Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy.
Ardissino G; Salardi S; Berra S; Colussi G; Cugno M; Zecca M; Giglio F; Peccatori J; Diral E; Tel F; Clivio A; Tedeschi S
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1580-1582. PubMed ID: 28522344
[TBL] [Abstract][Full Text] [Related]
16. [Advances in research on haematopoietic stem cell transplantation-associated thrombotic microangiopathy].
Chen X; Feng SZ
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):560-3. PubMed ID: 22338184
[No Abstract] [Full Text] [Related]
17. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
Front Immunol; 2021; 12():695037. PubMed ID: 34326846
[TBL] [Abstract][Full Text] [Related]
18. [Management of transplant-associated thrombotic microangiopathy].
Ikezoe T
Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
[TBL] [Abstract][Full Text] [Related]
19. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
[TBL] [Abstract][Full Text] [Related]
20. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
Lazana I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]